(Q36490855)

14 August 2017

1 reference

title

The challenge of long-acting beta-adrenoceptor agonists (English)

1 reference

14 August 2017

K F Rabe

1

1 reference

14 August 2017

K F Chung

series ordinal

2

1 reference

14 August 2017

publication date

1 January 1991

1 reference

14 August 2017

1 reference

14 August 2017

volume

85

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

5-9

1 reference

A new approach to the treatment of asthma

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Differentiation of Receptor Systems activated by Sympathomimetic Amines

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Effects of N-aralkyl substitution of β-agonists on α- and β-adrenoceptor subtypes: pharmacological studies and binding assays

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Basic pharmacology of new long-acting sympathomimetics

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Formoterol and salbutamol metered aerosols: comparison of a new and an established beta-2-agonist for their bronchodilating efficacy in the treatment of childhood bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Effect of formoterol, a long-lasting beta 2-adrenoceptor agonist, against methacholine-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Prophylaxis of exercise-induced asthma with inhaled formoterol, a long-acting beta 2-adrenergic agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Long-term studies on long-acting sympathomimetics

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Long-term efficacy of formoterol compared to salbutamol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Anti-Allergic Activity of Formoterol, a New Beta-Adrenoceptor Stimulant, and Salbutamol in Human Leukocytes and Human Lung Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

Inhibition of anti-IgE induced skin response in normals by formoterol, a new beta 2-adrenoceptor agonist, and terbutaline. 2. Effect on the late phase reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980203-9

7 January 2021

10.1016/S0954-6111(06)80203-9

Identifiers

DOI

1 reference

release_t7kcimoxubgz3cyohiapt5oitu

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t7kcimoxubgz3cyohiapt5oitu

24 November 2022

mapped directly with Wikidata item

1 reference